Skip to the main content

Review article

DIAGNOSTIC APPROACH AND THERAPY FOR CYTOMEGALOVIRUS (CMV) INFECTION FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION

Nataša Beader
Smilja Kalenić
Boris Labar


Full text: croatian pdf 298 Kb

downloads: 796

cite


Abstract

In spite of improvements in diagnostics and prevention of CMV disease in recent decades, CMV infection still remains major concern in terms of diagnosis and therapy in recipients of allogeneic stem cells. Besides considerable morbidity with direct effects of CMV infection (hepatitis, gastrointestinal disease, pneumonia, retinitis), there are also indirect effects such as increased susceptibility to opportunistic infections and an increased risk of graft rejection and transplant-related mortality. Also, myelosuppression, nephrotoxicity and emergence of drug-resistant CMV strains may limit the use of antiviral agents for the control of CMV infection. The aim of this paper is to show the problems associated with CMV infection in recipients of allogeneic stem cells with special emphasis on diagnostic procedures and treatment or prophylaxis of CMV disease.

Keywords

Cytomegalovirus infections – diagnosis, drug therapy, prevention and control; Antiviral agents – therapeutic use; Hematopoietic stem cell transplantation; Transplantation, homologous

Hrčak ID:

171891

URI

https://hrcak.srce.hr/171891

Publication date:

29.12.2011.

Article data in other languages: croatian

Visits: 1.785 *